These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7808075)

  • 21. Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count.
    Mañas E; Pulido F; Peña JM; Rubio R; Gonzalez-García J; Costa R; Pérez-Rodríguez E; Del Palacio A
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):451-7. PubMed ID: 15141738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease of CD4 cell number and function in HIV-seropositive hemophiliacs in a longitudinal study.
    Knutsen AP; Bouhasin JD; Joist JH; Scrivner D; Mueller KR; Gioia K; Janney S
    Ann Allergy; 1989 Sep; 63(3):189-94. PubMed ID: 2528308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
    Goujard C; Bonarek M; Meyer L; Bonnet F; Chaix ML; Deveau C; Sinet M; Galimand J; Delfraissy JF; Venet A; Rouzioux C; Morlat P;
    Clin Infect Dis; 2006 Mar; 42(5):709-15. PubMed ID: 16447119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
    Peerlinck K; Arnout J; Gilles JG; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1993 Feb; 69(2):115-8. PubMed ID: 8456422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.
    Gjerset GF; Pike MC; Mosley JW; Hassett J; Fletcher MA; Donegan E; Parker JW; Counts RB; Zhou Y; Kasper CK
    Blood; 1994 Sep; 84(5):1666-71. PubMed ID: 7915149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantification of viremia in patients infected with human immunodeficiency virus with different degrees of immunosuppression].
    Soriano V; Gómez-Cano M; Mas A; Villalba N; Castilla J; Adrados M; Laguna F; Polo R; González-Lahoz J
    Rev Clin Esp; 1997 Dec; 197(12):810-3. PubMed ID: 9477671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum levels of soluble tumor necrosis factor receptors as markers for disease progression of human immunodeficiency virus infection].
    Hattori M; Tateyama M; Oishi T; Miyasaka S; Fukutake K
    Rinsho Byori; 1997 Nov; 45(11):1085-90. PubMed ID: 9396350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of clotting factor concentrates on the immune system in HIV-negative haemophilics.
    Balkan C; Kavakli K; Kutukculer N; Aksu G; Yilmaz D; Aydinok Y
    Haemophilia; 2005 Jul; 11(4):366-70. PubMed ID: 16011589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
    Armbruster C; Kriwanek S; Vorbach H
    Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of monoclonal or ion-exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparison.
    Hay CR; Ludlam CA; Lowe GD; Mayne EE; Lee RJ; Prescott RJ; Lee CA
    Br J Haematol; 1998 Jun; 101(4):632-7. PubMed ID: 9674733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical analysis of four Chinese hemophiliacs with human immunodeficiency virus infection.
    Tang DJ; Xu YH; Dai D; Han YJ; Wang BC; Lang YM; Liang Y; Zeng Y
    Chin Med J (Engl); 1989 Nov; 102(11):819-24. PubMed ID: 2517721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of high- versus intermediate-purity blood coagulation factor concentrates on HIV-1 replication.
    Schögl D; Zimmermann K; Turecek PL; Schwarz HP; Eibl MM; Mannhalter JW
    Vox Sang; 1996; 70(4):195-7. PubMed ID: 9123922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].
    Astermark J; Berntorp E; Stigendal L; Johnsson H
    Lakartidningen; 1998 Jan; 95(1-2):48-50. PubMed ID: 9458646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoresponsiveness in hemophilia: lymphocyte- and phagocyte-mediated functions.
    Antonaci S; Jirillo E; Stasi D; De Mitrio V; La Via MF; Bonomo L
    Diagn Clin Immunol; 1988; 5(6):318-25. PubMed ID: 3219781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.